The monthly variation in acute anterior uveitis in a community-based ophthalmology practice

Ocular Immunology and Inflammation

Volumn 10, Issue 2, 2002, Pages 133-139

  Levinson, Ralph D ^a,c,d   Greenhill, Leah H ^b  

^a Eye Associates of New Mexico   (United States)

^b MERCY HOSPITAL OF PITTSBURGH   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epidemiology; HLA B27; Uveitis

Indexed keywords

HLA B27 ANTIGEN;

ACUTE DISEASE; ARTICLE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; SEASONAL VARIATION; UNITED STATES;

ACUTE DISEASE; COMMUNITY HEALTH SERVICES; FEMALE; HLA-B27 ANTIGEN; HUMANS; MALE; NEW MEXICO; OPHTHALMOLOGY; RETROSPECTIVE STUDIES; RISK FACTORS; SEASONS; UVEITIS, ANTERIOR;

EID: 0038331657     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.1076/ocii.10.2.133.13983     Document Type: Article

References (24)

1. McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in general practice of ophthalmology. Am J Ophthalmol. 1996;121(1):35-46.
2. Linssen A, Meenken C. Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis. Am J Ophthalmol. 1995;120(3):351-361.
3. Rothova A, van Veenendaal MS, Linssen A, et. al. Clinical features of acute anterior uveitis. Am J Ophthalmol. 1987;103(2):137-145.
4. Wakefield D, Easter J, Penny R. Clinical features of HLA-B27 anterior uveitis. Aust J Ophthalmol. 1984;12:191-196.
5. Tay-Kearney ML, Schwam BL, Lowder C, et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996;121(1):47-56.
6. Saari KM, Laitinen O, Leirisalo M, Saari R. Ocular inflammation associated with Yersinia infection. Am J Ophthalmol. 1980;89:84-95.
7. Careless DJ, Chiu B, Rabinovitch T, et al. Immunogenetic and microbial factors in acute anterior uveitis. J Rheumatol. 1997;24:102-108.
8. Larkin DF, Cafferkey MT, Eustace P. Yersinia-induced uveitis in Ireland. Br J Ophthalmol. 1988;72:938-941.
9. Saari KM, Maki M, Paivonsalo T, et al. Acute anterior uveitis and conjunctivitis following yersinia infection in children. Int Ophthalmol. 1986;9:237-241.
10. Feltkamp, T. Are gram negative bacteria involved in HLA-B27 associated uveitis? Br J Ophthalmol. 1995;79:718.
11. Banares A, Jover JA, Fernandez-Gutierrez B, et al. Bowel inflammation in anterior uveitis and spondylarthropathy. J Rheumatol. 1995;22(6):1112-1117.
12. Cassel GH, Burrows A, Jeffers JB, Fischer DH. Anterior nongranulomatous uveitis: a seasonal variation. Ann Ophthalmol. 1984;16(11):1066-1068.
13. Ebringer R, White L, McCoy R, Tait B. Seasonal variation of acute anterior uveitis: differences between HLA-B27 positive and HLA-B27 negative disease. Br J Ophthalmol. 1985;69(3):202-204.
14. Chung YM, Yeh TS, Liu JH. Clinical manifestations of HLA-B27-positive acute anterior uveitis in Chinese. Chung Hua I Hsueh Tsa Chih (Taipei). 1989;43(2):97-104.
15. Mercanti A, Parolino A, Bonora A, et al. Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta Ophthalmol Scand. 2001;79(1):64-68.
16. Paivonsalo-Hietanen T, Tuominen J, Saari KM. Seasonal variation of endogenous uveitis in south-western Finland. Acta Ophthalmol Scand. 1998;76(5):599-602.
17. Hogan M, Kimura SJ, Thygeson P. Signs and symptoms of uveitis. Am J Ophthalmol. 1959;47:155-170.
18. Linssen A. B27+ disease versus B27-disease. Scand J Rheumatol. 1990; Suppl. 87:111-119.
19. Kloner RA, Poole WK, Perritt RL. When throughout the year is coronary death most likely to occur? Circulation. 1999;100(15):1590-1592.
20. Yamamoto H, Azumi A, Sakai J, Yamamoto M. The Kobe earthquake and recurrent endogenous uveitis. Jpn J Ophthalmol. 1997;41(2):111-114.
21. Secchi AG, Magni G, Tognon MS, et al. A psychosomatic approach to idiopathic recurrences of anterior uveitis. Am J Ophthalmol. 1987;104(2):174-178.
22. Mulholland B, Marks M, Lightman SL. Anterior uveitis and its relation to stress. Br J Ophthalmol. 2000;84:1121-1124.
23. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180(6):2359-2364.
24. Baggia S, Lyons JL, Angell E, et al. A novel model of bacterially-induced acute anterior uveitis in rats and the lack of effect from HLA-B27 expression. J Invest Med. 1997;45(5):295-301.